United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 18, 2026 · Filed Jun 22, 2026

On Jun 18, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$540.18 for US$5.13M under a trading plan, leaving 40,513 shares. Filed Jun 22, 2026 (Form 4).

Sold
9,500 shares
Price
US$540.18 average (US$533.79 to US$552.72)
Value
US$5.13M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 18, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 18, 2026Common StockSale480US$533.7949,533Direct
Jun 18, 2026Common StockSale80US$535.0149,453Direct
Jun 18, 2026Common StockSale245US$536.5949,208Direct
Jun 18, 2026Common StockSale828US$537.5248,380Direct
Jun 18, 2026Common StockSale1,399US$538.5946,981Direct
Jun 18, 2026Common StockSale2,793US$539.6244,188Direct
Jun 18, 2026Common StockSale2,022US$540.5242,166Direct
Jun 18, 2026Common StockSale613US$541.4941,553Direct
Jun 18, 2026Common StockSale40US$544.0141,513Direct
Jun 18, 2026Common StockSale40US$545.1941,473Direct
Jun 18, 2026Common StockSale320US$547.5141,153Direct
Jun 18, 2026Common StockSale480US$548.8440,673Direct
Jun 18, 2026Common StockSale160US$552.7240,513Direct

Source

View original at SEC

Related